ScreenerHero

MYNDMYND Lifesciencs Inc.

CNQ · CA · Healthcare · Biotechnology · myndsciences.com
0.0700CADMkt Cap: 2.44M $P/E: —

MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap2.44M $
Enterprise Value4.62M $
Revenue (TTM)1 $
Gross Profit-174.78K $
Net Income (TTM)-1.11M $
Revenue/Share0.0000 USD
Last Price0.0700 CAD
Fiscal Year EndOct 2023
MR QuarterJul 2024
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-4.94
EV/Revenue6346705.00
P/S3347203.00
P/B-0.56
EPS (TTM)-0.02
EPS (Forward)—
52W Range
—
52W High0.0700 CAD
52W Low0.0700 CAD
Profitability
Gross Margin0.00%
Oper. Margin-128598000.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE30.50%
ROA-190.32%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-144.38K $
CapEx (TTM)—
FCF Margin-65803700.00%
FCF Yield-19.66%
Net Debt2.18M $
Net Debt/EBITDA-2.34
Balance Sheet
Debt/Equity-0.60
Current Ratio0.09
Quick Ratio0.09
Book Value/Sh-0.1250 CAD
Cash/Share0.0000 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.47.82M
Float33.24M
Insiders59.83%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short1.60K
Short (prev mo.)252
Technical
SMA 500.0700 (+0.0%)
SMA 2000.0700 (+0.0%)
Beta0.94
S&P 52W Chg18.16%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)100.0
MACD0.0000
MACD Signal0.0000
MACD Hist.+0.0000
BB Upper0.0700 CAD
BB Middle0.0700 CAD
BB Lower0.0700 CAD
BB Width0.00%
ATR (14)0.0000 CAD
Vol Ratio (20d)—